BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23184096)

  • 1. Cancer stem cells: the 'heartbeat' of gastric cancer.
    Xu G; Shen J; Ou Yang X; Sasahara M; Su X
    J Gastroenterol; 2013 Jul; 48(7):781-97. PubMed ID: 23184096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer stem cells: evidence, potential markers, and clinical implications.
    Brungs D; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
    J Gastroenterol; 2016 Apr; 51(4):313-26. PubMed ID: 26428661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between gastric cancer stem cells and the tumor microenvironment.
    Ishimoto T; Sawayama H; Sugihara H; Baba H
    J Gastroenterol; 2014 Jul; 49(7):1111-20. PubMed ID: 24652101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells in human gastrointestinal cancer.
    Taniguchi H; Moriya C; Igarashi H; Saitoh A; Yamamoto H; Adachi Y; Imai K
    Cancer Sci; 2016 Nov; 107(11):1556-1562. PubMed ID: 27575869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
    Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells in gastric cancer.
    Zhao Y; Feng F; Zhou YN
    World J Gastroenterol; 2015 Jan; 21(1):112-23. PubMed ID: 25574084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The self-renewal signaling pathways utilized by gastric cancer stem cells.
    Fu Y; Li H; Hao X
    Tumour Biol; 2017 Apr; 39(4):1010428317697577. PubMed ID: 28378630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell metabolism: target for cancer therapy.
    Chae YC; Kim JH
    BMB Rep; 2018 Jul; 51(7):319-326. PubMed ID: 29764565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor.
    Becerril-Rico J; Alvarado-Ortiz E; Toledo-Guzmán ME; Pelayo R; Ortiz-Sánchez E
    Stem Cell Res Ther; 2021 Sep; 12(1):498. PubMed ID: 34503571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
    Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
    Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms.
    Jiang YX; Yang SW; Li PA; Luo X; Li ZY; Hao YX; Yu PW
    Oncogene; 2017 Mar; 36(9):1256-1264. PubMed ID: 27524415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
    Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
    Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gastric cancer stem cells using the cell surface marker CD44.
    Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
    Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.
    Pajuelo-Lozano N; Alcalá S; Sainz B; Perona R; Sanchez-Perez I
    Theranostics; 2020; 10(21):9601-9618. PubMed ID: 32863948
    [No Abstract]   [Full Text] [Related]  

  • 19. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of cancer stem cells.
    Yang C; Jin K; Tong Y; Cho WC
    Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.